We partner with healthcare and biotechnology companies to navigate critical moments by communicating the science, strategy, and value behind their innovation.
The new Russo Partners website is live. Explore our Insights hub, the Russo Edge Podcast, and how we work across media, IR, digital, and strategy to translate complex science into clear stories. bit.ly/3WtK0Il#Biotech#LifeSciences#Healthcare#PR
Biopharma dealmaking entered 2026 with momentum. According to @BioXconomy’s Millie Nelson, licensing partnerships reached $82.7B in announced value in Q1, while M&A totaled $40.9B across 32 deals. bit.ly/4uomdcg#Biopharma#Dealmaking#MandA
When a high-stakes @US_FDA decision shifted unexpectedly, Russo Partners helped a client respond quickly with expert commentary that shaped early media narratives. The result: A @WSJ placement, broader syndication, and meaningful share of voice. bit.ly/4uGK7AS
Healthcare sales does not move on awareness alone. On the Russo Edge, Scott Becker of Becker’s Healthcare joins @SolomonsWisdom to discuss why small and midsize companies need internal champions who see the solution as worth testing and advancing.
💬 Interview: bit.ly/4cGx8qS
🎧 Apple Podcasts: apple.co/4cEs1r7@BKRBusinessMin @BeckerHR | #Healthcare#Hospitals#Podcast
Generating TV and radio mentions across 45 states, a @RussoPartners broadcast and digital media campaign helped a biotech client build national awareness around a regulatory milestone.
Have an important milestone ahead? See how the right strategy can help extend its reach: bit.ly/4dBMTRz#HealthcareCommunications#Biotech#MediaRelations
mRNA is more than a vaccine technology. It is a strategic platform capability. Tony Russo, Ph.D., of @RussoPartners, shares Board of Advisors insights on why the U.S. risks losing ground in mRNA infrastructure while other countries and global organizations continue moving forward. bit.ly/3QNkUFC#Biotech#mRNA#LifeSciences#Innovation#Leadership
Patients are increasingly going outside traditional hospital and health system channels to access care.
On Russo Edge, @SolomonsWisdom speaks with Scott Becker of Becker's Healthcare about telehealth, GLP-1s, and shifting access models.
✔️ Interview and video: bit.ly/4cGx8qS
🎧 Apple Podcasts: apple.co/4cEs1r7@BKRBusinessMin @BeckerHR | #Healthcare#Hospitals#Podcast
What’s driving pressure on hospitals, and what does it mean for companies working with them?
On Russo Edge, @SolomonsWisdom speaks with Scott Becker of Becker’s Healthcare about hospital access, staffing, reimbursement, tech adoption, and tighter buying decisions.
✔️ Check out the interview and video: bit.ly/4cGx8qS
🎧 Apple Podcasts: apple.co/4cEs1r7@BKRBusinessMin | #Healthcare#Hospitals#Podcast
Biotech M&A is becoming more selective. Demand for late-stage assets is rising as companies prepare for loss of exclusivity, but high-quality assets remain scarce. That imbalance is pushing the industry toward more disciplined capital allocation and risk-shared partnerships.
Read the great coverage by @BioXconomy from BIO-Europe Spring in Lisbon. bit.ly/4ce1OAU#Biotech#Pharma#MandA
Sports media can drive more than awareness. Our @RussoPartners Sports-Health Alliance case study shows how a five-year Super Bowl Radio Row program helped a medical organization expand awareness, connect audiences to care resources, and drive measurable action, with 150 placements and an 80.5% YoY increase in direct traffic. bit.ly/4vGW0rp#HealthcareCommunications#MediaRelations#SportsHealth